Cargando…
Surgery for cholangiocarcinoma
Surgical resection is the only potentially curative treatment for patients with cholangiocarcinoma. For both perihilar cholangiocarcinoma (pCCA) and intrahepatic cholangiocarcinoma (iCCA), 5‐year overall survival of about 30% has been reported in large series. This review addresses several challenge...
Autores principales: | Cillo, Umberto, Fondevila, Constantino, Donadon, Matteo, Gringeri, Enrico, Mocchegiani, Federico, Schlitt, Hans J., Ijzermans, Jan N. M., Vivarelli, Marco, Zieniewicz, Krzysztof, Olde Damink, Steven W. M., Groot Koerkamp, Bas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563077/ https://www.ncbi.nlm.nih.gov/pubmed/30843343 http://dx.doi.org/10.1111/liv.14089 |
Ejemplares similares
-
Curative effect of xanthohumol supplementation during liver fluke-associated cholangiocarcinogenesis: Potential involvement of autophagy
por: Thongchot, Suyanee, et al.
Publicado: (2019) -
Intrahepatic cholangiocarcinoma: current perspectives
por: Buettner, Stefan, et al.
Publicado: (2017) -
Robotic hepatectomy and biliary reconstruction for perihilar cholangiocarcinoma: a pioneer western case series
por: Cillo, Umberto, et al.
Publicado: (2021) -
Unchanged surgical management of patients with Cholangiocarcinoma during the COVID-19 pandemic
por: Gringeri, Enrico, et al.
Publicado: (2020) -
Cholangiocarcinoma as an Indication for Liver Transplantation in the Era of Transplant Oncology
por: Gringeri, Enrico, et al.
Publicado: (2020)